Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

822 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cilostazol uncovers covert atrial fibrillation in non-cardioembolic stroke.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS investigators. Aoki J, et al. Among authors: kaneko n. J Neurol Sci. 2020 Jun 15;413:116796. doi: 10.1016/j.jns.2020.116796. Epub 2020 Mar 21. J Neurol Sci. 2020. PMID: 32222589 Clinical Trial.
Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
Saji N, Kimura K, Tateishi Y, Fujimoto S, Kaneko N, Urabe T, Tsujino A, Iguchi Y; daVinci Study Group. Saji N, et al. Among authors: kaneko n. J Thromb Thrombolysis. 2016 Nov;42(4):453-62. doi: 10.1007/s11239-016-1376-x. J Thromb Thrombolysis. 2016. PMID: 27207691 Clinical Trial.
Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS Investigators. Aoki J, et al. Among authors: kaneko n. J Am Heart Assoc. 2019 Aug 6;8(15):e012652. doi: 10.1161/JAHA.119.012652. Epub 2019 Jul 26. J Am Heart Assoc. 2019. PMID: 31347430 Free PMC article. Clinical Trial.
Risk factors, etiology, and outcome of ischemic stroke in young adults: A Japanese multicenter prospective study.
Kono Y, Terasawa Y, Sakai K, Iguchi Y, Nishiyama Y, Nito C, Suda S, Kimura K, Kanzawa T, Imafuku I, Nakayama T, Ueda M, Iwanaga T, Kono T, Yamashiro K, Tanaka R, Okubo S, Nakajima M, Nakajima N, Mishina M, Yaguchi H, Oka H, Suzuki M, Osaki M, Kaneko N, Kitagawa K, Okamoto S, Nomura K, Yamazaki M, Nagao T, Murakami Y. Kono Y, et al. Among authors: kaneko n. J Neurol Sci. 2020 Oct 15;417:117068. doi: 10.1016/j.jns.2020.117068. Epub 2020 Jul 29. J Neurol Sci. 2020. PMID: 32745720
Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc Analysis.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS investigators. Aoki J, et al. Among authors: kaneko n. J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105494. doi: 10.1016/j.jstrokecerebrovasdis.2020.105494. Epub 2020 Dec 2. J Stroke Cerebrovasc Dis. 2021. PMID: 33278804
Microbleeds and clinical outcome in acute mild stroke patients treated with antiplatelet therapy: ADS post-hoc analysis.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K. Aoki J, et al. Among authors: kaneko n. J Clin Neurosci. 2021 Jul;89:216-222. doi: 10.1016/j.jocn.2021.04.028. Epub 2021 May 12. J Clin Neurosci. 2021. PMID: 34119270
YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy).
Aoki J, Kimura K, Morita N, Harada M, Metoki N, Tateishi Y, Todo K, Yamagami H, Hayashi K, Terasawa Y, Fujita K, Yamamoto N, Deguchi I, Tanahashi N, Inoue T, Iwanaga T, Kaneko N, Mitsumura H, Iguchi Y, Ueno Y, Kuramoto Y, Ogata T, Fujimoto S, Yokoyama M, Nagahiro S; YAMATO Study Investigators. Aoki J, et al. Among authors: kaneko n. Stroke. 2017 Mar;48(3):712-719. doi: 10.1161/STROKEAHA.116.015042. Epub 2017 Jan 24. Stroke. 2017. PMID: 28119434 Clinical Trial.
Successful treatment of hemodynamic compromise caused by antibody-mediated and cellular rejection in a recipient 12 years after heart transplantation.
Imamura T, Kinugawa K, Kato N, Kagami Y, Endo M, Kaneko N, Minatsuki S, Muraoka H, Inaba T, Maki H, Hatano M, Doi K, Yao A, Takazawa Y, Ono M, Kyo S, Komuro I. Imamura T, et al. Among authors: kaneko n. Int Heart J. 2013;54(5):328-31. doi: 10.1536/ihj.54.328. Int Heart J. 2013. PMID: 24097224 Free article.
822 results